Validating the New Remote Hypnotic Induction Profile (rHIP)

Testing the Hypnotizability of Healthy Volunteers Clinical Trial

Official title:

A Randomized Trial Validating the New Remote Hypnotic Induction Profile (rHIP) Against the Existing Hypnotic Induction Profile (HIP)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04058483
• Other study ID #: 51970
• Status: Completed
• Phase: N/A
• Start date: September 13, 2019
• Est. completion date: October 14, 2019

Study information

• Verified date: October 2019
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to determine if hypnotizability can be reliably tested over the phone, without having to see or touch a patient. The scores from a new test for hypnotizability by phone will be compared to the scores from a standard in-person test, to make sure the results are similar.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: October 14, 2019
• Est. primary completion date: October 14, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• At least 18 years old.

• Able to schedule a 15 minute in-person and phone appointment within a week of each other, during the study period.

Exclusion Criteria:

• Severe psychiatric or structural brain disease (ie. psychosis, stroke with functional impairment, dementia)

• Has had prior hypnotizability testing using the HIP or enrolled in another hypnosis-related trial.

• hearing impairment that would preclude phone interviewing

• non-English speakers

Related Conditions & MeSH terms

• Testing the Hypnotizability of Healthy Volunteers

Intervention

Other:
• Hypnotizability testing
Hypnotizability testing in-person vs. by phone. All participants will complete both conditions.

Locations

Country	Name	City	State
United States	Stanford University/Stanford Healthcare	Palo Alto	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reliability of HIP and rHIP test scores	Calculate the correlation between the HIP and rHIP	Through study completion, approximately 2 months.
Secondary	Hypnotizability and DES	Investigate any correlation between hypnotizability scores and the Dissociative Experiences Scale	Administered upon enrollment, prior to first hypnotizability test
Secondary	Hypnotizability and Tellegen	Investigate any correlation between hypnotizability scores and the Tellegen Absorption Scale	Administered upon enrollment, prior to first hypnotizability test
Secondary	Complications with phone-administered test	Researchers will recored the % of participants who reported technical or practical difficulties with the phone-administered test including difficulty hearing, understanding the instructions, getting interrupted during the test, or others.	Through study completion, approximately 2 months.